Dudley M N, Nightingale C H, Drezner A D, Low H B, Quintiliani R
Antimicrob Agents Chemother. 1984 Sep;26(3):347-50. doi: 10.1128/AAC.26.3.347.
The penetration of cefonicid and cefazolin into cardiac tissue was compared after a single 30-mg/kg dose in 30 patients undergoing aortocoronary artery bypass graft surgery. Samples of the right atrial appendage, pericardial fluid, and serum were obtained at various times and assayed for drug content. The concentrations of cefonicid in serum and the atrial appendage were at least twice those observed for cefazolin at a given time after a dose. The mean (+/- standard deviation) atrial appendage-serum ratio was 0.47 +/- 0.14 for cefonicid and 0.34 +/- 0.06 for cefazolin (P less than 0.005). Pericardial fluid concentrations of cefonicid were slightly lower than those observed in patients receiving cefazolin (P greater than 0.05). A single intravenous dose of cefonicid provides high and sustained concentrations in serum and cardiac tissue and thus may be useful in antibiotic prophylaxis of certain surgical procedures; however, further study of the efficacy of this agent in the prevention and treatment of infections associated with Staphylococcus spp. is needed.
在30例接受主动脉冠状动脉搭桥手术的患者中,单次给予30mg/kg剂量后,比较了头孢尼西和头孢唑林在心脏组织中的渗透情况。在不同时间获取右心耳、心包液和血清样本,并检测药物含量。给药后特定时间,血清和心耳中头孢尼西的浓度至少是头孢唑林的两倍。头孢尼西的心耳-血清平均(±标准差)比值为0.47±0.14,头孢唑林为0.34±0.06(P<0.005)。头孢尼西的心包液浓度略低于接受头孢唑林治疗的患者(P>0.05)。单次静脉注射头孢尼西可在血清和心脏组织中提供高且持续的浓度,因此可能有助于某些外科手术的抗生素预防;然而,需要进一步研究该药物在预防和治疗与葡萄球菌属相关感染方面的疗效。